Anlotinib Not Yet Recruiting Phase N/A Trials for Cancer of Liver Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03766776Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC)